Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is malignant glomus tumor (glomangiosarcoma)?
A glomus tumor is a small growth that arises from the glomus body, a tiny structure in the skin that helps regulate body temperature by controlling blood flow, often found under the fingernails. The vast majority of glomus tumors are completely benign and simply cause pain or sensitivity. Very rarely, a glomus tumor is malignant — a cancer sometimes called glomangiosarcoma or 'malignant glomus tumor.' These are diagnosed when a glomus tumor shows worrisome features under the microscope: large size, deep location, atypical cells, or a high rate of cell division. Most malignant glomus tumors behave in a borderline fashion and are cured by complete removal, but a minority can spread to distant sites, especially the lungs. Because it is so rare, an experienced pathologist is essential to make the diagnosis and distinguish it from its common benign relative. Note: this is different from the 'glomus tumors' of the head and neck (paragangliomas), which are a separate condition.
The main types
Doctors group malignant glomus tumor (glomangiosarcoma) by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Glomus tumor of uncertain malignant potential | A borderline category with some worrisome features but not enough for a clear cancer diagnosis. These are removed completely and watched closely. |
| Malignant glomus tumor (glomangiosarcoma) | A true cancerous form with clearly atypical, rapidly dividing cells. Most are cured by wide removal, but some can spread, most often to the lungs. |
Staging, in plain terms
There is no glomus-tumor-specific staging system. When a glomus tumor is malignant, it is staged like other soft-tissue sarcomas — based on the tumor's size and depth (T), spread to lymph nodes (N, uncommon), spread to distant organs (M, most often the lungs), and its grade (how aggressive the cells look). Because most are small and caught early, they usually fall into earlier stages, but careful follow-up is important because spread can occur late.
| Soft-tissue sarcoma TNM + grade | What it generally means |
|---|---|
| Localized, low-risk | A small tumor confined to where it started, with limited worrisome features. Usually cured by complete wide surgical removal. |
| Localized, high-risk | A larger, deeper, or more aggressive-appearing tumor. Treated with wide surgery, with radiation added to reduce the chance of local recurrence. |
| Metastatic | The cancer has spread, most often to the lungs. Treated with surgery or radiation to problem areas and systemic therapy or clinical trials. |
The standard of care
Malignant Glomus Tumor (Glomangiosarcoma) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Wide surgical removal (the main treatment)
Completely removing the tumor with a margin of healthy tissue around it is the primary treatment and cures most malignant glomus tumors.
Radiation therapy
Radiation is added after surgery for large, deep, or high-grade tumors, or when margins are close or positive, to lower the risk of the cancer returning where it started. It can also treat tumors that can't be removed.
Lung surveillance
Because malignant glomus tumors most often spread to the lungs, follow-up imaging of the chest is used to catch any spread early, when it may still be treatable.
Systemic therapy for advanced disease
For the rare cases that spread widely, chemotherapy, targeted therapy, or clinical trials are considered, guided by an expert sarcoma team.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide. For malignant glomus tumor, surgery is the main treatment, but radiation is an important partner when the risk of the cancer returning is higher — for large, deep, or high-grade tumors, or when surgical margins are close or positive — because it treats the microscopic cells left behind and lowers the chance of local recurrence. Shaped external-beam radiation concentrates the dose on the tumor bed while sparing surrounding skin, nerves, tendons, and joints, which matters because these tumors often occur on the hand. If the cancer spreads to a small number of spots in the lungs, focused stereotactic radiation (SBRT) can treat those precisely. Radiation is painless during delivery, given over a series of sessions, and external-beam treatment leaves no radioactivity in the body.
The main ways radiation is delivered for malignant glomus tumor (glomangiosarcoma):
External-beam radiation (IMRT)
Shaped beams treat the tumor bed after surgery while sparing surrounding skin, nerves, and — for tumors on the hand — tendons and joints.
Stereotactic body radiation (SBRT)
Focused high-dose radiation can treat a small number of lung metastases precisely when the cancer has spread there.
Brachytherapy (selected)
In some sarcomas, radioactive sources placed close to the tumor bed deliver a concentrated dose to a small area while sparing nearby tissue.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Criteria for diagnosing malignancy: Pathology research defined the features that separate benign glomus tumors, borderline tumors of uncertain malignant potential, and true malignant glomus tumors — guiding when aggressive treatment and close follow-up are needed.[1]
American Journal of Surgical Pathology glomus-tumor classification (Folpe et al.)
Surgery-centered treatment with selective radiation: Because malignant glomus tumors are so rare, evidence comes mainly from case series, which support wide surgical removal as the cornerstone and radiation for high-risk or unresectable disease, mirroring soft-tissue sarcoma principles.[2]
Soft-tissue sarcoma case series and reviews
Lung as the main site of spread: Reported cases of metastatic disease most often involve the lungs, supporting chest imaging during follow-up so spread can be found and treated early.[3]
Sarcoma outcome and case-report literature
Common questions
Aren't glomus tumors usually harmless? Yes — the vast majority of glomus tumors are completely benign and cause only pain or sensitivity, often under a fingernail. A malignant glomus tumor is very rare and is diagnosed only when the tumor shows specific worrisome features under the microscope. An experienced pathologist is essential to tell the two apart.
Is this the same as a 'glomus tumor' in the head or neck? No. The head-and-neck 'glomus tumors' (such as glomus jugulare or glomus tympanicum) are actually paragangliomas — a different condition with its own treatment. The malignant glomus tumor described here is a skin/soft-tissue tumor related to the temperature-regulating glomus body, often in the hand.
Will I need anything beyond surgery? Most malignant glomus tumors are cured by complete wide removal. Radiation is added for larger, deeper, or more aggressive tumors, or when margins are close, to lower the risk of recurrence. Because spread to the lungs can occur, your team will also recommend follow-up chest imaging.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- American Journal of Surgical Pathology glomus-tumor classification (Folpe et al.) (no indexed identifier — see your care team) ↩
- Soft-tissue sarcoma case series and reviews (no indexed identifier — see your care team) ↩
- Sarcoma outcome and case-report literature (no indexed identifier — see your care team) ↩